Optimal Teicoplanin Trough Concentration With Therapeutic Drug Monitoring in Children: A Systematic Review and Meta-analysis.

Yuki HanaiKazutaka OdaTakashi UedaKazuaki MatsumotoLisa MurakamiShusuke UekusaHayato OhashiKoji NishimuraYoshio TakesueKazuhiro Matsuo

Published in: Therapeutic drug monitoring (2024)

Although further prospective studies are required for validation, the authors' findings suggest that 10- to 20-mcg/mL teicoplanin is the optimal trough concentration for enhanced clinical success and reduced toxicity in pediatric patients.

Keyphrases

young adults
oxidative stress
case control
oxide nanoparticles